Equine Metabolic Syndrome (EMS) and pituitary pars intermedia dysfunction (PPID) and are the most common hormonal disorders in adult horses. Although both conditions have been described worldwide, those diseases have a specific significance in Australia; for instance, in Queensland, it has been shown that more than 20% of aged horses are suffering from PPID and that more than a third of them are also suffering from EMS.
Both conditions have a huge impact on equine health as they both result in laminitis. Laminitis is a painful and incurable condition, and even though it has been a major burden on the equine industry for many years, there is still no adequate treatment. Therefore, prevention of the first painful episode of laminitis is critical when managing horses at risk of developing hormonal dysregulation.
This presentation will review the current understanding of both EMS and PPID and will also describe the diagnostic tests that can be used to improve the early detection of horses at risk. Finally, this presentation will discuss the different therapeutic options available.
This webinar is sponsored by ASAP Laboratory
Recording from 04.04.2018
Speaker:
François-René Bertin
DVM, MS, PhD
François-René is a member of the Equine Endocrinology Focus Group, an international panel of experts in equine endocrinology, as well as a member of the Equine Endocrinology Special Interest Group of the American College of Veterinary Internal Medicine.
